Acacia Research Q3 revenue down 36% YoY to $10.1M; net income $1.6M but diluted EPS loss $0.03

ACACIA RESEARCH CORP

2023-Q3 EPS reported -$0.23 revenue$32,791,000

Revenue $10.1M vs $15.9M YoY; operating loss widened to $15.4M from $11.4M.
GAAP net income $1.6M ($0.03 diluted loss per share) vs $28.1M ($0.02 EPS) YoY.
Acquired majority stake in Benchmark Energy II LLC on Nov 13 for oil and gas growth.
Agreed to sell Arix Bioscience stake for $57.1M cash; expected close Q1 2024.
Board approved $20M stock repurchase program (up to 5.8M shares) on Nov 9.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

ACACIA RESEARCH CORP reported financial results for three and nine months ended September 30, 2023.

Period: three and nine months ended September 30, 2023
Result: reported results

Exact text from the filing

On November 13, 2023, Acacia Research Corporation (the "Corporation) issued a press release announcing its financial results for the quarter ended September 30, 2023.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

ACACIA RESEARCH CORP filing history →

Source: SEC EDGAR

accession 0000934549-23-000098

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.